AFib alongside heart failure, stroke and other conditions
Last reviewed November 17, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.
AFib usually turns up in a heart that already has something else going on, and the combinations change the treatment rather than just adding to it.
The most consequential pairing is with heart failure, where each condition makes the other worse.
Related pages: Atrial fibrillation (AFib)
The bottom line
- AFib and heart failure commonly coexist and worsen each other.
- An overactive thyroid can cause AFib and is a reversible cause.
- Kidney function determines anticoagulant choice and dose.
- Valve disease, especially mitral, both causes AFib and changes anticoagulant choice.
- A persistently fast rate can itself weaken the heart, and that is reversible.
- How best to sequence treatment when AFib and heart failure coexist.
- How to anticoagulate safely in advanced kidney disease.
- Whether rhythm control changes outcomes in heart failure more broadly.
The story, step by step
What the evidence labels mean
A two-way street
What happens
Each one drives the other.
What the research shows
- Heart failure raises pressure in the atria, stretching them and making AFib more likely. AFib reduces pumping efficiency and worsens heart failure.
- Once both are present they tend to reinforce each other, and treating only one often leaves the person unwell.
- Losing the atrial kick matters much more in a stiff or weakened ventricle than in a healthy one, which is why the same rhythm causes worse symptoms here.
- A persistently fast rate can weaken the ventricle on its own. This tachycardia-induced cardiomyopathy is often substantially reversible once the rate is controlled.
- Drug choice changes: non-dihydropyridine calcium channel blockers such as diltiazem and verapamil are generally avoided in heart failure with reduced ejection fraction.
- Trial evidence supports catheter ablation in selected people with AFib and heart failure, with benefits beyond symptoms alone.
Why it matters
New or worsening breathlessness, ankle swelling or sudden weight gain in someone with AFib should prompt a review rather than being attributed to the rhythm.
What's still uncertain
- Who benefits most from ablation in heart failure.
- How to sequence the two treatments optimally.
Read more
- NHLBI: Heart failureGovernment
- MedlinePlus: Heart failureGovernment
- NHLBI: Atrial fibrillationGovernment
Next: Thyroid disease
The reversible cause
What happens
Checked at diagnosis for good reason.
What the research shows
- An overactive thyroid speeds the heart and raises electrical irritability, and can cause AFib outright.
- Thyroid function is therefore checked at diagnosis, because treating the thyroid may resolve the rhythm without further cardiac treatment.
- Symptoms can be subtle in older adults, sometimes amounting to little more than fatigue, weight loss and a fast pulse.
- Amiodarone, one of the antiarrhythmic drugs, contains iodine and can cause both underactive and overactive thyroid, so thyroid function is monitored during treatment.
- An underactive thyroid is less directly linked but is worth correcting as part of general management.
- Even when the thyroid is treated successfully, AFib can return later, so follow-up continues.
Why it matters
A thyroid blood test is cheap, quick and occasionally changes the entire treatment plan, which is why it is a standard part of the workup.
What's still uncertain
- How often AFib resolves permanently after thyroid treatment.
- How long to anticoagulate in thyroid-related AFib.
Read more
- MedlinePlus: Thyroid diseasesGovernment
- NHLBI: Atrial fibrillationGovernment
- MedlinePlus: Atrial fibrillationGovernment
Next: Kidney disease
Where dosing gets complicated
What happens
Kidneys decide the anticoagulant.
What the research shows
- Most direct oral anticoagulants are cleared partly by the kidneys, so kidney function determines both the choice of drug and its dose.
- Kidney function is checked before starting and rechecked periodically, more often in older people and those with existing impairment.
- In advanced kidney disease the evidence is thinner and the choice becomes more individualised, sometimes favouring warfarin.
- Kidney disease raises both stroke risk and bleeding risk at once, which makes the balance harder rather than clearer.
- Acute illness can reduce kidney function temporarily, and dosing may need adjusting during and after it.
- This is one reason not to carry on indefinitely on an old prescription without review.
Why it matters
An unchanged anticoagulant dose over many years in an ageing person with changing kidneys is a genuine risk, and periodic review is the safeguard.
What's still uncertain
- How to anticoagulate safely in dialysis patients.
- Which drug is preferable in advanced impairment.
Read more
- MedlinePlus: Blood thinnersGovernment
- NHLBI: Atrial fibrillationGovernment
- MedlinePlus: Atrial fibrillationGovernment
Related problems
What happens
Where the labels matter.
What the research shows
- Mitral valve disease raises left atrial pressure directly and is a classic cause of AFib. Significant valve disease may be correctable, which changes the outlook.
- Mechanical heart valves and some rheumatic mitral stenosis require warfarin rather than a direct oral anticoagulant. This is one of the few absolute distinctions in anticoagulant choice.
- Atrial flutter is a related but more organised rhythm, usually from a single large circuit, often faster and more regular. It carries similar stroke risk and is frequently very treatable with ablation.
- Many people have both flutter and fibrillation at different times.
- Harmless extra beats, felt as skips or thuds, are extremely common and are not AFib, though they feel similar and often prompt the investigation that finds AFib.
- Pacemakers and implanted defibrillators store rhythm data, which sometimes reveals AFib nobody suspected.
Why it matters
If you have a mechanical valve, the anticoagulant question is already answered, and a direct oral anticoagulant is not an appropriate substitute.
What's still uncertain
- How best to treat coexisting flutter and fibrillation.
- How to handle device-detected AFib in pacemaker patients.
Read more
- NHLBI: Atrial fibrillationGovernment
- MedlinePlus: Pacemakers and implantable defibrillatorsGovernment
- MedlinePlus: ArrhythmiaGovernment